SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-292084
Filing Date
2021-10-05
Accepted
2021-10-05 16:15:13
Documents
16
Period of Report
2021-10-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d222930d8k.htm   iXBRL 8-K 49067
2 EX-3.1 d222930dex31.htm EX-3.1 9194
3 EX-3.2 d222930dex32.htm EX-3.2 93065
4 EX-4.1 d222930dex41.htm EX-4.1 25981
5 EX-10.1 d222930dex101.htm EX-10.1 73587
  Complete submission text file 0001193125-21-292084.txt   437977

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA xers-20211005.xsd EX-101.SCH 2901
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xers-20211005_lab.xml EX-101.LAB 19639
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xers-20211005_pre.xml EX-101.PRE 12318
9 EXTRACTED XBRL INSTANCE DOCUMENT d222930d8k_htm.xml XML 3736
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 211306792
SIC: 2834 Pharmaceutical Preparations